You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Topoisomerase I Inhibitors

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neuroblastoma Trial in Guangzhou (Naxitamab monotherapy, GM-CSF, Irinotecan)

Recruiting
  • Neuroblastoma
  • Naxitamab monotherapy
  • +6 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Aug 31, 2023

HRD Cancer, SCLC, Advanced Solid Tumors Trial run by the NCI (Berzosertib, Sacituzumab Govitecan)

Recruiting
  • HRD Cancer
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 20, 2023

Transplant; Failure, Heart, Cardiac Allograft Vasculopathy, Rejection Heart Transplant Trial (SGLT2i)

Not yet recruiting
  • Transplant; Failure, Heart
  • +2 more
  • (no location specified)
Nov 19, 2023

(NIS) on Sodium-glucose Co-transporter-2 Inhibitors Use in

Not yet recruiting
  • Diabetes Mellitus, Type 2
  • Sodium/glucose cotransporter-2 inhibitors (SGLT2i)
  • (no location specified)
May 22, 2023

Heart Failure, Reduced Ejection Fraction Heart Failure Trial in Damanhur (Empagliflozin 10 MG, Dapagliflozin 10 MG)

Recruiting
  • Heart Failure
  • Reduced Ejection Fraction Heart Failure
  • Empagliflozin 10 MG
  • Dapagliflozin 10 MG
  • Damanhūr, Elbehairah, Egypt
    Damanhour Teaching Hospital, General Organization for Teaching H
Oct 3, 2023

Metastatic Lung Small Cell Carcinoma, Metastatic Malignant Solid Tumor, Metastatic Neuroendocrine Carcinoma Trial in United

Recruiting
  • Metastatic Lung Small Cell Carcinoma
  • +16 more
  • Phoenix, Arizona
  • +10 more
Mar 25, 2022

NSCLC, Low Dose Radiotherapy, Stereotactic Body Radiotherapy Trial in Chengdu (Low Dose Radiotherapy, stereotactic body

Not yet recruiting
  • NSCLC
  • +3 more
  • Low Dose Radiotherapy
  • +2 more
  • Chengdu, Sichuan, China
    West China Hospital, Sichuan University
Nov 11, 2022

SGLT2-I Use in DFUD: a Delphi Study

Not yet recruiting
  • Diabetic Foot Ulcer
  • eDelphi method
  • (no location specified)
Aug 14, 2023

Hormone Receptor-positive Advanced Breast Cancer Trial (chidamide combined with fulvestrant)

Not yet recruiting
  • Hormone Receptor-positive Advanced Breast Cancer
  • chidamide combined with fulvestrant
  • (no location specified)
Mar 28, 2023

Heart Failure With Reduced Ejection Fraction Trial in Chicago (SGLT2i, No SGLT2i)

Recruiting
  • Heart Failure With Reduced Ejection Fraction
  • Chicago, Illinois
    University of Chicago
Nov 11, 2022

Hemophilia A With Inhibitor, Hemophilia B With Inhibitor, Factor VII Deficiency Trial in China (SS109)

Recruiting
  • Hemophilia A With Inhibitor
  • +2 more
  • SS109
  • Hefei, Anhui, China
  • +9 more
Jan 12, 2023

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial

Recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +15 more
  • Dietary Intervention
  • +2 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Jun 23, 2022

Tuberculous Meningitis, HIV I Infection Trial in Rio De Janeiro, Maputo, Lusaka (Adalimumab Injection)

Not yet recruiting
  • Tuberculous Meningitis
  • HIV I Infection
  • Adalimumab Injection
  • Rio De Janeiro, Brazil
  • +2 more
Jan 31, 2023

Fatty Liver, Nonalcoholic Trial (SGLT2 inhibitor)

Not yet recruiting
  • Fatty Liver, Nonalcoholic
  • SGLT2 inhibitor
  • (no location specified)
Oct 31, 2023

Called FLAMINgO to Learn More About Treatment Combination of

Active, not recruiting
  • Chronic Kidney Disease
  • Type 2 Diabetes
  • Finerenone (Kerendia, BAY94-8862)
  • Sodium-glucose cotransporter-2 inhibitors (SGLT2i)
  • Whippany, New Jersey
    Bayer
Jan 19, 2023

Acute Decompensated Heart Failure Trial in Chicago (SGLT2i, No SGLT2i)

Not yet recruiting
  • Acute Decompensated Heart Failure
  • Chicago, Illinois
    University of Chicago
Jun 10, 2022

Advanced Melanoma, Metastatic Melanoma Trial in Saint Louis (Memory-like natural killer cells, Relatilmab, Nivolumab)

Not yet recruiting
  • Advanced Melanoma
  • Metastatic Melanoma
  • Memory-like natural killer cells
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Nov 16, 2022

Erectile Dysfunction Following Radiation Therapy, Phosphodiesterase Inhibitor Adverse Reaction, Platelet- Rich Plasma (PRP)

Active, not recruiting
  • Erectile Dysfunction Following Radiation Therapy
  • +2 more
  • P shot arm ( Autologous Platelet Rich Plasma)
  • PDE5i arm
  • Mansoura, Outside U.S./Canada, Egypt
    Mansoura urology and nephrology center
Mar 15, 2023

Breast Cancer, Breast Cancer Metastatic Trial in Spain (Niraparib 100 MG, Aromatase Inhibitors)

Terminated
  • Breast Cancer
  • Breast Cancer Metastatic
  • Niraparib 100 MG
  • Aromatase Inhibitors
  • A Coruña, Spain
  • +9 more
Jan 17, 2023

Empagliflozin in Type 2 Diabetes Population With and Without

Not yet recruiting
  • Diabetes Mellitus, Type 2
  • Durham, North Carolina
    Duke Clinical Research Institute
Aug 8, 2022

HIV I Infection, Cardiovascular Risk Factor, Lipid Metabolism Disorders Trial (Doravirine 100 Mg)

Recruiting
  • HIV I Infection
  • +2 more
  • Doravirine 100 Mg
  • Los Angeles, California
  • +1 more
Nov 1, 2022

SGLT2-I in Diabetic AMI (SGLT2-I AMI PROTECT Study)

Recruiting
  • Diabetes Mellitus
  • Acute Coronary Syndrome
    • Aalst, Belgium
    • +6 more
    Mar 2, 2022

    Influenza Vaccination, ACEI and ARB in Evolution of SARS-Covid19

    Recruiting
    • COVID19
    • +3 more
    • Terrassa, Barcelona, Spain
      Hospital de Terrassa
    Mar 9, 2022

    Based on Data From German Sick Funds That Looks at Costs of

    Completed
    • Diabetes Mellitus, Type 2
    • Ingelheim am Rhein, Germany
      Boehringer Ingelheim
    Jan 18, 2022

    IgA Nephropathy, Immunoglobulin A Nephropathy Trial (Atrasentan, Placebo)

    Not yet recruiting
    • IgA Nephropathy
    • Immunoglobulin A Nephropathy
    • (no location specified)
    Apr 27, 2023